Security key
15117K103
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)
CUSIP: 15117K103
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Ordinary Shares, nominal value EUR0.05 per share
- Total 13F shares
- 5,703,192
- Total 13F value
- $136,879,000
- Share change
- +43,979
- Put/Call ratio
- 463%
- SEC-reported price per share
- $24.00
- Number of holders
- 39
- Value change
- +$1,857,397
- Number of buys
- 16
- Number of sells
- 15
- Shares outstanding
- 95,490,450
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2017
Institutions
39
Top holders
10
CLLS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Cellectis S.A. SEC filings
Cellectis S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117K103
Recent filing periods:
Ownership snapshot
Top reported holders of CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 3.7%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 3.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
3.7%
ORBIMED ADVISORS LLC
0.37%
Tekla Capital Management LLC
0.32%
LAZARD ASSET MANAGEMENT LLC
0.31%
FRANKLIN RESOURCES INC
0.26%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
3.7%
|
$59,840,000
3,530,406 shares
|
— | 31 Dec 2016 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.37%
|
$5,933,000
350,000 shares
|
— | 31 Dec 2016 |
| Tekla Capital Management LLC |
13F
Company
|
0.32%
|
$5,259,000
310,250 shares
|
— | 31 Dec 2016 |
| LAZARD ASSET MANAGEMENT LLC |
13F
Company
|
0.31%
|
$5,097,000
300,754 shares
|
— | 31 Dec 2016 |
| FRANKLIN RESOURCES INC |
13F
Company
|
0.26%
|
$4,131,000
243,700 shares
|
— | 31 Dec 2016 |
| Artal Group S.A. |
13F
Company
|
0.16%
|
$2,543,000
150,000 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
5,703,192
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
36
Q1 2017 holders
39
Holder diff
3
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend